Cargando…

An Update on Breast Cancer Multigene Prognostic Tests—Emergent Clinical Biomarkers

Multigene signatures generate crucial prognostic information particularly useful for cancer patients where clinical parameters and traditional immunohistochemical markers alone lead to equivocal prognosis. Clinicians are now provided with molecular tools that assist in the outline of adjuvant therap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vieira, André Filipe, Schmitt, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131478/ https://www.ncbi.nlm.nih.gov/pubmed/30234119 http://dx.doi.org/10.3389/fmed.2018.00248

Ejemplares similares

Multigene prognostic tests in breast cancer: past, present, future
por: Győrffy, Balázs, et al.
Publicado: (2015)

Multigene tests for breast cancer: the physician’s perspective
por: Cognetti, Francesco, et al.
Publicado: (2021)

Editorial: Update on diagnostic and prognostic biomarkers for women's cancers
por: Zhu, Yunxia, et al.
Publicado: (2023)

Tumor microenvironment-related multigene prognostic prediction model for breast cancer
por: Hong, Kai, et al.
Publicado: (2022)

Detection of germline variants in Brazilian breast cancer patients using multigene panel testing
por: Guindalini, Rodrigo Santa Cruz, et al.
Publicado: (2022)

Multigene Panel Testing for Hereditary Cancer Risk
por: Grissom, Alyssa A., et al.
Publicado: (2016)

From Clinical Diagnosis to the Discovery of Multigene Rare Sequence Variants in Pseudoxanthoma elasticum: A Case Report
por: Lofaro, Francesco Demetrio, et al.
Publicado: (2021)

The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
por: Asphaug, Lars, et al.
Publicado: (2019)

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer
por: Sun, Li, et al.
Publicado: (2019)

Clinical outcomes based on multigene profiling in metastatic breast cancer patients
por: Basho, Reva K., et al.
Publicado: (2016)

Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from Singapore
por: Wong, Edward S Y, et al.
Publicado: (2016)

Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients
por: Tedaldi, Gianluca, et al.
Publicado: (2020)

Importance of multigene panel test in patients with consanguineous marriage and family history of breast cancer
por: Ozmen, Vahit, et al.
Publicado: (2022)

Molecular profiling of male breast cancer by multigene panel testing: Implications for precision oncology
por: Valentini, Virginia, et al.
Publicado: (2023)

Integrated multigene expression panel to prognosticate patients with gastric cancer
por: Kanda, Mitsuro, et al.
Publicado: (2018)

Application of Multigene Panels Testing for Hereditary Cancer Syndromes
por: Bilyalov, Airat, et al.
Publicado: (2022)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Cross comparison and prognostic assessment of breast cancer multigene signatures in a large population-based contemporary clinical series
por: Vallon-Christersson, Johan, et al.
Publicado: (2019)

Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
por: Shimelis, Hermela, et al.
Publicado: (2018)

Racial and Ethnic Differences in Multigene Hereditary Cancer Panel Test Results for Women With Breast Cancer
por: Yadav, Siddhartha, et al.
Publicado: (2020)

Multigene testing panels reveal pathogenic variants in sporadic breast cancer patients in northern China
por: Liu, Yinfeng, et al.
Publicado: (2023)

Exon splicing analysis of intronic variants in multigene cancer panel testing for hereditary breast/ovarian cancer
por: Ryu, Jin‐Sun, et al.
Publicado: (2020)

Novel Ferroptosis-Related Multigene Prognostic Models for Patients with Bladder Cancer
por: Zhang, Shun, et al.
Publicado: (2021)

Multigene Panel Testing in Turkish Hereditary Cancer Syndrome Patients
por: ARSLAN ATES, Esra, et al.
Publicado: (2022)

Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing
por: Zhang, Zeng-Yun-Ou, et al.
Publicado: (2021)

The Role of Multigene Assays in Addressing Treatment Heterogeneity for Breast Cancer
por: Aapro, Matti
Publicado: (2017)

Nectin-4 Expression Is an Independent Prognostic Biomarker and Associated With Better Survival in Triple-Negative Breast Cancer
por: Zeindler, Jasmin, et al.
Publicado: (2019)

Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool?
por: Albergaria, André, et al.
Publicado: (2011)

Loss-of-function variants in CTNNA1 detected on multigene panel testing in individuals with gastric or breast cancer
por: Clark, Dana Farengo, et al.
Publicado: (2020)

Genetic Variation and the Role of Multigene Panel Testing for Hereditary Breast Cancer: A Single-Institution Experience
por: Lu, Kit, et al.
Publicado: (2021)

PROCURE European consensus on breast cancer multigene signatures in early breast cancer management
por: Curigliano, Giuseppe, et al.
Publicado: (2023)

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer
por: Lhotova, Klara, et al.
Publicado: (2020)

Multigene testing of moderate-risk genes: be mindful of the missense
por: Young, E L, et al.
Publicado: (2016)

Update on systemic treatment for newly diagnosed inflammatory breast cancer
por: Chainitikun, Sudpreeda, et al.
Publicado: (2020)

From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis
por: Brase, Jan C., et al.
Publicado: (2013)

Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population
por: GOIDESCU, IULIAN GABRIEL, et al.
Publicado: (2018)

Optimizing the identification of risk‐relevant mutations by multigene panel testing in selected hereditary breast/ovarian cancer families
por: Coppa, Anna, et al.
Publicado: (2017)

The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
por: Eliade, Marie, et al.
Publicado: (2016)

Racial and Ethnic Differences in BRCA1/2 and Multigene Panel Testing Among Young Breast Cancer Patients
por: Jones, T, et al.
Publicado: (2019)

Exploration of intermediate-sized INDELs by next-generation multigene panel testing in Han Chinese patients with breast cancer
por: Hata, Chihiro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0hr2a6oh4im6u1rf2tihjucfum